-+ 0.00%
-+ 0.00%
-+ 0.00%

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga·11/20/2024 21:10:51
Listen to the news

Gainers

  • Quantum-Si (NASDAQ:QSI) stock rose 144.9% to $1.55 during Wednesday's pre-market session. The company's market cap stands at $221.2 million.
  • Forte Biosciences (NASDAQ:FBRX) shares moved upwards by 76.53% to $10.46. The company's market cap stands at $15.2 million. The company's, Q3 earnings came out 4 days ago.
  • Silexion Therapeutics (NASDAQ:SLXN) stock rose 72.36% to $0.39. The company's market cap stands at $5.6 million. As per the news, the Q3 earnings report came out 4 days ago.
  • Tonix Pharmaceuticals (NASDAQ:TNXP) shares moved upwards by 57.59% to $0.26. The market value of their outstanding shares is at $47.9 million.
  • Exicure (NASDAQ:XCUR) shares rose 21.13% to $7.05. The company's market cap stands at $15.3 million. As per the press release, Q3 earnings came out 4 days ago.
  • Tevogen Bio Holdings (NASDAQ:TVGN) shares moved upwards by 19.85% to $1.63. The company's market cap stands at $278.1 million.

Losers

  • Lineage Cell Therapeutics (AMEX:LCTX) shares declined by 19.7% to $0.72 during Wednesday's pre-market session. The company's market cap stands at $136.9 million. As per the press release, Q3 earnings came out 4 days ago.
  • Apollomics (NASDAQ:APLM) shares declined by 17.23% to $0.14. The company's market cap stands at $14.9 million.
  • BrightSpring Health (NASDAQ:BTSGU) stock declined by 16.86% to $56.38.
  • Oncology Institute (NASDAQ:TOI) stock fell 15.56% to $0.15. The market value of their outstanding shares is at $11.4 million.
  • HCW Biologics (NASDAQ:HCWB) shares declined by 15.35% to $0.93. The market value of their outstanding shares is at $35.2 million. As per the news, the Q3 earnings report came out 4 days ago.
  • Eyenovia (NASDAQ:EYEN) shares decreased by 13.93% to $0.1. The market value of their outstanding shares is at $8.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.